Showing results (471-480 of 8,521) with videos related to
Sort By:
Pageof 853
Alimentary Pharmacology & Therapeutics|March 6, 2002
The effects of the specific 5HT(4) receptor agonist, prucalopride, on colonic motility in healthy volunteersA M P De Schryver, G I Andriesse, M Samsom, et al.Alimentary Pharmacology & Therapeutics|August 1, 1993
Anti-secretory effects and pharmacokinetics of low dose ranitidineM A Koss, D L Hogan, J Lane, et al.Alimentary Pharmacology & Therapeutics|August 1, 1993
Effect of treatment with liu-jun-zi-tang (TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patientsM Tatsuta, H IishiAlimentary Pharmacology & Therapeutics|August 1, 1993
Short report: treatment of Helicobacter pylori-associated duodenal ulcer with omeprazole plus antibioticsC J McCarthy, R Collins, S Beattie, et al.Alimentary Pharmacology & Therapeutics|June 1, 1997
Clinical economics review: liver transplantationJ G O'GradyAlimentary Pharmacology & Therapeutics|June 1, 1997
Comparison of two dosing regimens of cisapride in the treatment of reflux oesophagitisK Schütze, M A Bigard, L Van Waes, et al.Alimentary Pharmacology & Therapeutics|June 1, 1997
The long-term management of patients with bleeding duodenal ulcersM E McAlindon, J S Taylor, S D RyderAlimentary Pharmacology & Therapeutics|June 1, 1997
Doubling the omeprazole dose (40 mg b.d. vs. 20 mg b.d.) in dual therapy with amoxycillin increases the cure rate of Helicobacter pylori infection in duodenal ulcer patientsJ Labenz, J A Beker, C P Dekker, et al.Alimentary Pharmacology & Therapeutics|June 1, 1997
Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practiceR H Jones, G BaxterAlimentary Pharmacology & Therapeutics|June 1, 1997
Evaluation of a new quality of life questionnaire for patients with irritable bowel syndromeB A Hahn, L J Kirchdoerfer, S Fullerton, et al.Pageof 853